Accretion Pharmaceuticals weak stock market entry disappoints investors
New Delhi, May 21 (H.S.): Accretion Pharmaceuticals, a healthcare product and pharmaceutical company, faced a disappointing debut on the stock market today, disappointing IPO investors. The shares were issued at ₹101 under the IPO but started trading at ₹79, a 21.78% discount on the NSE’s SME platform. Despite receiving buying support that pushed the share…